Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology

British Journal of Cancer

Volumn 80, Issue 8, 1999, Pages 1281-1288

  Shimada, Y ^a   Imamura, M ^a   Watanabe, G ^a   Uchida, S ^a   Harada, H ^a   Makino, T ^a   Kano, M ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Biological marker; Cyclin D1; E cadherin; Molecular marker; Oesophageal cancer

Indexed keywords

CD9 ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P16; PROTEIN P21; PROTEIN P53; UVOMORULIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0033035666     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6990499     Document Type: Article

References (55)

1. Akiyama H, Tsurumaru M, Udagawa H and Kajiyama Y (1994) Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220: 364-373
2. Akselen LA and Varhaug JE (1995) Oncoproteins and tumour progression in papillary thyroid carcinoma. Cancer 76: 1643-1654
3. Bukholm IK, Nesland JM, Karesen R, Jacobsen U and Borresen-Dale AL (1997) Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53. Int J Cancer 73: 38-41
4. Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B and Slamon DJ (1996) DNA sequence analysis of exon 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13: 1971-1981
5. Coggi G, Bosari S, Roncalli M, Graziani D, Bossi P, Viale G, Buffa R, Ferrero S, Piazza M, Blandamura S, Segalin A, Bonavina L and Peracchia A (1997) P53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer 79: 425-432
6. Cox DR (1972) Regression models and life tables. J R Stat Soc (B) 34: 187-220
7. Higashiyama M, Doi O, Kodama K, Yokouchi H, Kasugai T, Ishiguro S, Takami K, Nakayama T and Nishisho I (1997) MDM2 gene amplification and expression in non-small-cell lung cancer: immunohistochemical expression of its protein is a favorable prognostic marker in patients without p53 protein accumulation. Br J Cancer 75: 1302-1308
8. Imamura M, Shimada Y, Kanda Y, Miyahara T, Hashimoto M, Tobe T, Arai T and Hatano Y (1992) Hemodynamic changes after resection of thoracic duct for en bloc resection of esopbageal cancer. SurgToday 22: 226-232
9. Inoue K, Ozeki Y, Suganuma T, Sugiura Y and Tanaka S (1997) Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer 76: 206-213
10. Ishikawa T, Furihata M, Ohtsuki Y, Murakami H, Inoue A and Ogoshi S (1998) Cyelin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. Br J Cancer 77: 92-97
11. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S and Nagura H (1994) Epidermal growth factor receptor overexpression in esophageal carcinoma. Cancer 74: 795-804
12. Jiang W, Kahn SM, Tomiyta N, Tomita N, Zhang YJ, Lu SH and Weinstein IB (1992) Amplification and expression of the human cyclinD gene in esophageal cancer. Cancer Res 52: 2980-2983
13. Kadowaki T, Shiozaki H, Inouc M, Tamura S, Oka H, Doki Y, Iihara K, Matsui S, Iwazawa T, Nagafuchi A, Tsuikita S and Mori T (1994) E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54: 291-296
14. Kanda Y, Nishiyama Y, Shimada Y, Imamura M, Nomura H, Hiai H and Fukumoto (1994) Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines. Int J Cancer 58: 291-297
15. Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M and Kawase I (1997) p21 expression as a predictor for favourable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 3: 1831-1835
16. Maex J (1994) How cells cycle toward cancer. Science 263: 319-321
17. Maruyama K, Watanabe H, Shiozaki H, Takayama T, Gofuku J, Yano H, Inoue M, Tamura S, Raz A and Monden M (1995) Expression of autocrine motility factor receptor in human oesophageal squamous cell carcinoma. Int J Cancer 64: 316-321
18. Matsubara T, Kasai T, Ishiguro M and Nakajima T (1994) Better grading system for evaluating the degree of lymph node invasion in cancer of the thoracic esophagus. Surg Today 24. 500-505
19. Matsushime H, Roussel MF, Ashimun RA and Sherr CJ (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701-713
20. Miyake M, Nakano K, Itoi S, Koh T and Taki T (1996) Motility-rerated protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 56. 1244-1249
21. Miyata M, Shiozaki H, Iihara K, Shimaya K, Oka H, Kadowaki T, Inoue M, Tamura S, Takeichi M and Mori T (1994) Relationship between E-cadherin expression and lymph node metastasis in human esophageal cancer. Int J Oncol 4: 61-65
22. Mukaida H, Toi M, Hirai T, Yamashita Y and Toge T (1991) Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 68: 142-148
23. Naitoh H, Shibata J, Kawaguchi A, Kodama M and Haltori T (1995) Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161-1169
24. Nakagawa H, Zukerberg L, Togawa K, Meltzer SJ, Nishihata T and Rustgi AK (1995) Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer 76: 541-549
25. Nishimura Y, Ono K, Imamura M, Hiraoka M, Takahashi M, Abe M, Ohishi K. Yanagibashi K and Tobe T (1989) Postoperative radiation therapy for esophageal cancer. Radiation Medicine 7: 88-94
26. Ohbu M, Saegusa M, Kobayashi N, Tsukamoto H, Mieno H, Kakita A and Okayasu I (1997) Expression of bcl-2 protein in oesophageal squamous cell carcinomas and its association with lymph node metastasis. Cancer 79: 1287-1293
27. Ohtsubo M, Gamou S and Shimizu N (1998) Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells, Oncogene 16: 797-802
28. Ozawa S, Ueda M, Ando N, Shimizu N and Abe O (1988) Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer 63: 2169-2173
29. Paavonen K, Horelli K.N, Chilov D, Kukk-E, Pennanen S, Kallioniemi OP, Pajusola K, Otofsson B, Eriksson U, Joukov V, Palotie A and Alitalo K (1996) Novel human vascular endothelial growth factor genes VEGFb and VEGFc localize to chromosome 11q13 and 4q34, respectively. Circulation 93: 1079-1082
30. Ruol A, Segalin A, Panozzo M, Stephens JK, Dalla PP, Skinner DB, Peracchia A and Little AG (1990) Flow cytometric DNA analysis of squamous cell carcinoma of the esophagus. Cancer 65: 1185-1188
31. Sabin LH and Wittekind CH (1997) TNM Classification of Malignant Tumours, 5th edn. Wiley-Liss: New York
32. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R and Gabbert HE (1994) p53 protein expression and prognosis in squamous cell carcinoma of the oesophagus. Cancer 74: 2218-2223
33. Sarbia M, Brittinger F, Porshen R, Verreet P, Dutkowski P, Willers R and Gabbert HE (1996) Bcl2 expression and prognosis in squamous cell carcinomas of the oesophagus. Int J Cancer 69: 324-328
34. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M and Ishizaki K (1994) Allelotype analysis of oesophageal squamous cell carcinoma. Cancer Res 54: 2996-3000
35. Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M and Ishizaki K (1995) p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in oesophageal squamous cell carcinoma. Clin Cancer Res 1: 769-773
36. Shimada Y and Imamura M (1993) Prognostic significance of cell culture in carcinoma of the oesophagus. Br J Surg 80: 605-607
37. Shimada Y, Kanda Y, Wagata T, Shibagaki I, Toda S, Yamazoc Y, Maetani S and Imamura M (1994) Predictive factors in the recurrence of esophageal carcinoma after curative esophagectomy. Jpn J Gastroenterol Surg 27: 2273-2278
38. Shimada Y, Kanda Y, Shibagaki I, Kato M, Watanabe G, Tanaka H, Kano M and Imamura M (1996) The prognostic value of monolayer culture patterning in primary cell culture of oesophageal cancer. Br J Surg 83: 1148-1151
39. Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M and Ishizaki K (1997) Genetic alterations in patients with esophageal cancer with short-and long-term survival rates after curative esophagectomy. Ann Surg 226: 162-168
40. Shinozaki H, Ozawa S, Ando N, Tsuruta H, Terada M, Ueda M and Kitajima M (1996) Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus adding gene information. Clin Cancer Res 2: 1155-1161
41. Shiozaki H, Kadowaki T, Doki Y, Inoue M, Tamura S, Oka-H, Iwazawa T, Matsui S, Shimaya K, Takeichi M and Monden M (1995) Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line. Br J Cancer 71: 250-258
42. Sugimachi K, Matsuoka H, Matsufuji H, Maekawa S, Kai H and Okudaira Y (1987) Survival rates of women with carcinoma of the esophagus exceed those of men. Surg Gynecol Obster 164: 541-544
43. Takeuchi H, Ozawa S, Ando N, Shih CH, Koyanagi K, Ueda M and Kitajima M (1997) Altered p16/MTS1/CDKN2 and cyclin D1/PRAD1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3: 2229-2236
44. Tamura S, Shiozaki H, Miyata M, Kadowaki T, Inoue M, Matsui S, Iwazawa T, Takayama T, Takeichi M and Monden M (1996) Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus. Br J Surg 83: 1608-1614
45. Uchida S, Shimada Y, Watanabe G, Tanaka H, Shibagaki I, Miyahara T, Ishigami S, Arii S and Imamura M (1998) In oesophageal squamous carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 77: 1704-1709
46. Ueo H, Matsuoka H, Sugimachi K, Kuwano H, Mori M and Akiyoshi T (1990) Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res 50: 7212-7215
47. Utsumi Y, Nakamura T, Nagasue N, Kubota H and Morikawa S (1989) Role of estrogen receptors in the growth of human esophageal carcinoma. Cancer 64: 88-93
48. VanAndel JG, Dees J and Dijkhuis CM (1979) Carcinoma of me esophagus. Ann Surg 190: 684-689
49. Wagata T, Ishizaki K, Imamura M, Shimada Y, Ikenaga M and Tobe T (1991) Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res 51: 2113-2117
50. Wagata T, Shibagaki I, Imamurai M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T and Ishizaki K (1993) Loss of 17p, mutation of p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 53: 846-850
51. Wang DY, Xiang YY, Tanaka M, Li-XR, Li-JL, Shen Q, Sugimura H and Kino I (1994) High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 74: 3089-3096
52. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S and Mori T (1991) Immunohistologic detection of the epidermal growth factor in human esophageal squamous cell carcinoma. Cancer 67: 91-98
53. Youssef EM, Matsuda T, Takada N, Osugi H, Higashino M, Kinoshita H, Watanabe T, Katsura Y, Wanibuchi H and Fukushima S (1995) Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 76: 358-366
54. Zhou P, Jiang W, Zhang Y, Kahn SM, Schieren I, Santella RM and Weinstein IB (1995) Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11: 571-580
55. Zhou P, Jiang W, Weghorst CM and Weinstein IB (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56: 36-39